Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Change in Acquisitions & Divestments (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $91.0 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 5.22% to $91.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $380.8 million through Dec 2025, down 0.7% year-over-year, with the annual reading at $380.8 million for FY2025, 0.7% down from the prior year.
  • Change in Acquisitions & Divestments hit $91.0 million in Q4 2025 for Rocket Pharmaceuticals, down from $123.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $123.0 million in Q3 2025 to a low of $38.3 million in Q4 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $80.9 million across 5 years, with a median of $82.1 million in 2022.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 247.87% in 2021 and later dropped 23.97% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $38.3 million in 2021, then soared by 32.7% to $50.8 million in 2022, then soared by 42.35% to $72.3 million in 2023, then rose by 19.54% to $86.5 million in 2024, then increased by 5.22% to $91.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RCKT at $91.0 million in Q4 2025, $123.0 million in Q3 2025, and $84.5 million in Q2 2025.